A new Beginning..., page-2971

Not many shares traded, so can't draw any real conclusions in the price movement, better than going down .

Anyone with a chart would be crazy to prognosticate (but they do).

Good chance of some real movement either direction in the next month or 2 with progress milestones, FDA/TGA being the most important, and OS conference presentations, so happy to accumulate on the low side from here. No problem with the company story, ticks a few fashion topics (AI, Telehealth, Internet service provider), real world gaps in market exist or expensive alternatives, low overhead when app released. There are benefits to other larger telehealth providers to have this packaged up, will see, synergy in medical payment platforms, which may want to licence etc.

Sleep apnea hopefully will be the biggest market, given it is effective... so I am personally positive.